share_log

Individual Investors Who Have a Significant Stake Must Be Disappointed Along With Institutions After Inner Mongolia Furui Medical Science Co., Ltd.'s (SZSE:300049) Market Cap Dropped by CN¥1.1b

Individual Investors Who Have a Significant Stake Must Be Disappointed Along With Institutions After Inner Mongolia Furui Medical Science Co., Ltd.'s (SZSE:300049) Market Cap Dropped by CN¥1.1b

內蒙古福瑞醫療股份有限公司(SZSE:300049)的市值下降了11億元,機構和持有重要股權的個人投資者一定會感到失望。
Simply Wall St ·  09/02 19:14

Key Insights

主要見解

  • Significant control over Inner Mongolia Furui Medical Science by individual investors implies that the general public has more power to influence management and governance-related decisions
  • A total of 25 investors have a majority stake in the company with 44% ownership
  • Insider ownership in Inner Mongolia Furui Medical Science is 18%
  • 個人投資者對福瑞醫療的重大控制意味着普通大衆有更多的權力來影響管理和治理決策
  • 共有25名投資者擁有該公司的多數股份,佔股44%。
  • 福瑞醫療的內部股權比例爲18%

A look at the shareholders of Inner Mongolia Furui Medical Science Co., Ltd. (SZSE:300049) can tell us which group is most powerful. And the group that holds the biggest piece of the pie are individual investors with 53% ownership. In other words, the group stands to gain the most (or lose the most) from their investment into the company.

看一下福瑞醫療股份有限公司(SZSE:300049)的股東,我們可以得知哪個群體最具影響力。持有最大股份的群體是佔53%的個人投資者。換句話說,該群體最可能從他們對公司的投資中獲得最多(或者損失最多)。

While the holdings of individual investors took a hit after last week's 9.5% price drop, institutions with their 20% holdings also suffered.

儘管上週股價下跌9.5%,個人投資者持有的股份受到了打擊,但持有20%股份的機構也遭受了損失。

Let's take a closer look to see what the different types of shareholders can tell us about Inner Mongolia Furui Medical Science.

讓我們更近距離地觀察一下不同類型的股東對內蒙古福瑞股份有什麼樣的啓示。

big
SZSE:300049 Ownership Breakdown September 2nd 2024
SHSE:300049所有權拆分 2024年9月2日

What Does The Institutional Ownership Tell Us About Inner Mongolia Furui Medical Science?

機構所有權對內蒙古福瑞股份告訴我們什麼?

Institutions typically measure themselves against a benchmark when reporting to their own investors, so they often become more enthusiastic about a stock once it's included in a major index. We would expect most companies to have some institutions on the register, especially if they are growing.

機構通常在向自己的投資者報告時會針對一個基準進行衡量,因此一旦某隻股票被納入主要指數,他們通常會更加熱衷於該股票。我們預計大多數公司都會有一些機構在登記簿上,尤其是那些正在增長的公司。

Inner Mongolia Furui Medical Science already has institutions on the share registry. Indeed, they own a respectable stake in the company. This can indicate that the company has a certain degree of credibility in the investment community. However, it is best to be wary of relying on the supposed validation that comes with institutional investors. They too, get it wrong sometimes. It is not uncommon to see a big share price drop if two large institutional investors try to sell out of a stock at the same time. So it is worth checking the past earnings trajectory of Inner Mongolia Furui Medical Science, (below). Of course, keep in mind that there are other factors to consider, too.

內蒙古福瑞股份已經有機構在股東名冊上。實際上,他們在公司擁有一部分可觀的股份。這可能表示該公司在投資社區中具有一定的信譽度。然而,最好謹慎依賴機構投資者所帶來的所謂驗證。他們也會犯錯誤。如果兩個大型機構投資者試圖同時拋售股票,股價大幅下跌並不罕見。所以值得檢查一下內蒙古福瑞股份的過去盈利軌跡(如下)。當然,也要記住還有其他因素需要考慮。

big
SZSE:300049 Earnings and Revenue Growth September 2nd 2024
深證交易所:300049營收和收入增長報告 2024年9月2日

Hedge funds don't have many shares in Inner Mongolia Furui Medical Science. With a 11% stake, CEO Guanyi Wang is the largest shareholder. Meanwhile, the second and third largest shareholders, hold 6.0% and 2.9%, of the shares outstanding, respectively.

對於內蒙古福瑞醫療科學而言,對沖基金的持股不多。CEO王冠一持有11%的股份,是最大的股東。與此同時,第二和第三大股東分別持有流通股的6.0%和2.9%。

Our studies suggest that the top 25 shareholders collectively control less than half of the company's shares, meaning that the company's shares are widely disseminated and there is no dominant shareholder.

我們的研究表明,前25大股東共控制了公司股份的不到一半,這意味着公司的股份廣泛分散,沒有主導股東。

While studying institutional ownership for a company can add value to your research, it is also a good practice to research analyst recommendations to get a deeper understand of a stock's expected performance. There are plenty of analysts covering the stock, so it might be worth seeing what they are forecasting, too.

儘管研究公司的機構所有權可以爲您的研究增加價值,但研究分析師的建議也是一個好習慣,以深入了解股票的預期表現。有許多分析師對這支股票進行了覆蓋,因此了解他們的預測可能值得一試。

Insider Ownership Of Inner Mongolia Furui Medical Science

內蒙古福瑞醫療科學的內部持股情況

The definition of an insider can differ slightly between different countries, but members of the board of directors always count. Management ultimately answers to the board. However, it is not uncommon for managers to be executive board members, especially if they are a founder or the CEO.

在不同國家,內部人員的定義可能會略有不同,但董事會成員始終是內部人員。管理層最終向董事會負責。然而,如果管理人員是創始人或CEO,那麼成爲執行董事會成員也是很常見的。

Insider ownership is positive when it signals leadership are thinking like the true owners of the company. However, high insider ownership can also give immense power to a small group within the company. This can be negative in some circumstances.

當內部人持股情況表明領導層思考和公司真正所有者一樣時,內部所有權是積極的。然而,高達內部人士所有權也可能爲公司內的小團體帶來巨大的權力。在某些情況下,這可能是負面的。

It seems insiders own a significant proportion of Inner Mongolia Furui Medical Science Co., Ltd.. Insiders own CN¥1.9b worth of shares in the CN¥10b company. That's quite meaningful. It is good to see this level of investment. You can check here to see if those insiders have been buying recently.

內部人士擁有內蒙古福瑞醫療科技有限公司的相當大比例股份。內部人士持有總值100億元人民幣公司中的19億元人民幣的股份。這是相當有意義的。看到這種程度的投資是件好事。您可以在這裏查看內部人士最近是否一直在買入。

General Public Ownership

一般大衆所有權

The general public, mostly comprising of individual investors, collectively holds 53% of Inner Mongolia Furui Medical Science shares. This size of ownership gives investors from the general public some collective power. They can and probably do influence decisions on executive compensation, dividend policies and proposed business acquisitions.

普通投資者,主要由個人投資者組成,共同持有內蒙古福瑞醫療科技股份的53%。這種所有權規模賦予普通投資者一定的集體力量。他們可以並且很可能會影響執行薪酬、股利政策和擬議的業務收購決定。

Private Company Ownership

私有公司的所有權

It seems that Private Companies own 6.0%, of the Inner Mongolia Furui Medical Science stock. Private companies may be related parties. Sometimes insiders have an interest in a public company through a holding in a private company, rather than in their own capacity as an individual. While it's hard to draw any broad stroke conclusions, it is worth noting as an area for further research.

看起來,私營公司佔有內蒙古福瑞醫療科技6.0%的股份。私營公司可能是相關方。有時內部人士通過持有私營公司的股權而對公共公司有利益,而不是以個人的身份。雖然很難得出任何廣泛的結論,但這是值得進一步研究的領域。

Next Steps:

下一步:

I find it very interesting to look at who exactly owns a company. But to truly gain insight, we need to consider other information, too.

我覺得查看公司的實際所有者非常有趣。但爲了真正獲得洞察力,我們需要考慮其他信息。

Many find it useful to take an in depth look at how a company has performed in the past. You can access this detailed graph of past earnings, revenue and cash flow.

很多人覺得深入了解一家公司過去的表現是有用的。您可以訪問此詳細的過去收益、營業收入和現金流量圖。

If you are like me, you may want to think about whether this company will grow or shrink. Luckily, you can check this free report showing analyst forecasts for its future.

如果您像我一樣,可能希望考慮這家公司是否會增長或縮小。幸運的是,您可以查看此免費報告,顯示分析師對其未來的預測。

NB: Figures in this article are calculated using data from the last twelve months, which refer to the 12-month period ending on the last date of the month the financial statement is dated. This may not be consistent with full year annual report figures.

注:本文中的數據是使用最後一個財務報表日期結束的爲期12個月的數據計算的。這可能與全年年度報告數據不一致。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對本文有任何反饋?對內容有任何疑慮?請直接與我們聯繫。或者,發送電子郵件至editorial-team@simplywallst.com。
這篇文章是Simply Wall St的一般性文章。我們根據歷史數據和分析師預測提供評論,只使用公正的方法論,我們的文章並不意味着提供任何金融建議。文章不構成買賣任何股票的建議,也不考慮您的目標或您的財務狀況。我們的目標是帶給您基本數據驅動的長期關注分析。請注意,我們的分析可能不考慮最新的價格敏感公司公告或定性材料。Simply Wall St沒有任何股票頭寸。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論